Cargando…

Immunovirotherapy for the treatment of glioblastoma

We have recently described a new murine model of glioblastoma, generated by the implantation of syngeneic glioblastoma stem cells into immunocompetent mice, that recapitulates the salient histopathological and immunological features of the human disease. We employed this model to demonstrate the mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheema, Tooba A, Fecci, Peter E, Ning, Jianfang, Rabkin, Samuel D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929360/ https://www.ncbi.nlm.nih.gov/pubmed/24575383 http://dx.doi.org/10.4161/onci.27218

Ejemplares similares

Immunovirotherapy for glioblastoma
por: Ning, Jianfang, et al.
Publicado: (2014)

Oncolytic adenoviruses: A potent form of tumor immunovirotherapy
por: Cerullo, Vincenzo, et al.
Publicado: (2012)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV
por: Jahan, Nusrat, et al.
Publicado: (2021)

Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade
por: Bommareddy, Praveen K., et al.
Publicado: (2019)

Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastoma
por: Zhang, Mengxian, et al.
Publicado: (2012)

Immunological targeting of cytomegalovirus for glioblastoma therapy
por: Nair, Smita K, et al.
Publicado: (2014)

Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment
por: Schuessler, Andrea, et al.
Publicado: (2014)

Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy
por: Alvarez-Breckenridge, Christopher A., et al.
Publicado: (2013)

HDAC inhibitors and their potential applications to glioblastoma therapy
por: Adamopoulou, Eleni, et al.
Publicado: (2013)

SAT1 and glioblastoma multiforme: Disarming the resistance
por: Brett-Morris, Adina, et al.
Publicado: (2015)

Differentiation therapy for glioblastoma – too many obstacles?
por: Carén, Helena, et al.
Publicado: (2015)

Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus
por: Hollon, Todd C, et al.
Publicado: (2013)

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody
por: Choi, Bryan D, et al.
Publicado: (2013)

NORRIN plays a context-dependent role in glioblastoma stem cells
por: El-Sehemy, Ahmed, et al.
Publicado: (2020)

Increasing the accuracy of glioblastoma subtypes: Factoring in the tumor's cell of origin
por: Nelander, Sven
Publicado: (2018)

Convergence of EGFR glioblastoma mutations: evolution and allostery rationalizing targeted therapy
por: Orellana, Laura
Publicado: (2019)

AEG-1–AKT2: A novel complex controlling the aggressiveness of glioblastoma
por: Emdad, Luni, et al.
Publicado: (2015)

A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2013)

Functional characterization of ENPP1 reveals a link between cell cycle progression and stem-like phenotype in glioblastoma
por: Bageritz, Josephine, et al.
Publicado: (2014)

Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma
por: Kmiecik, Justyna, et al.
Publicado: (2014)

Intraventricular immunovirotherapy; a translational step forward
por: Bernstock, Joshua D., et al.
Publicado: (2023)

Mammaglobin-A is a target for breast cancer vaccination
por: Kim, Samuel W., et al.
Publicado: (2016)

Combined targeted therapy and immunotherapy in the treatment of advanced melanoma
por: Wilmott, James S., et al.
Publicado: (2012)

Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV(POS) Cancers
por: Suksanpaisan, Lukkana, et al.
Publicado: (2018)

Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas
por: Monie, Dileep D., et al.
Publicado: (2021)

Combining cellular and gene therapy approaches for treatment of intracranial tumors
por: Hickey, Michelle J, et al.
Publicado: (2013)

Cell-in-cell: A virgin land of cell biology
por: Wang, Ying, et al.
Publicado: (2013)

Rewiring cancer cell death to enhance oncolytic viro-immunotherapy
por: Workenhe, Samuel T, et al.
Publicado: (2013)

Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment
por: Foggetti, Giorgia, et al.
Publicado: (2022)

Macrophage-based immunotherapy for the treatment of pancreatic ductal adenocarcinoma
por: Beatty, Gregory L
Publicado: (2013)

Endosomal acidification inhibitors for the treatment of BRAF mutant tumors
por: Espinosa, Lluís
Publicado: (2015)

Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer
por: Nassif, Elise F., et al.
Publicado: (2021)

Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment
por: Demaria, Sandra, et al.
Publicado: (2013)

Triple threat treatment: Exploiting the dependence receptor properties of metabotropic glutamate receptor 1 against melanoma
por: Gelb, Tara, et al.
Publicado: (2014)

Local immunomodulation for cancer therapy: Providing treatment where needed
por: Fransen, Marieke F, et al.
Publicado: (2013)

TRPV1: Turning up the heat on intestinal tumorigenesis
por: de Jong, Petrus R, et al.
Publicado: (2014)

Interleukin-2 treatment of tumor patients can expand regulatory T cells
por: Beyer, Marc
Publicado: (2012)

Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma
por: Beatty, Gregory L
Publicado: (2014)

Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment
por: Michielsen, Adriana J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fs5p5ueulu3bbtrurrq2nhb1pd